Our group investigates brain signaling mechanisms and molecules and how they are related to neurological and psychiatric disorders.
We are particularly interested in neurodevelopmental disorders (such as ADHD and autism) and neurodegenerative diseases, including Parkinson’s disease. We have discovered risk factors for neuropsychiatric disorders and are exploring proteins involved in brain functions, with the aim of developing new therapies. These proteins include enzymes involved in the synthesis of serotonin, dopamine and noradrenaline, enzymes involved in antioxidant defense and several regulatory and scaffolding proteins, such as 14-3-3 proteins.
The Haavik lab is part of the neurotargeting research group at the Department of Biomedicine.
Figure: Gyrid Nygård